Lockheed Martin CEO says company pouring billions into missile output after Trump’s defense push

Lockheed Martin is accelerating weapons production and capex, investing $3.6 billion in capex and IRAD in 2025 and planning to increase that to $5.0 billion in 2026 (a 35% rise) in response to policy pressure to prioritize manufacturing over buybacks. The company will quadruple THAAD output from roughly 96 to 400 units annually over the next three years, broke ground on a munitions acceleration center in Arkansas, and signed a seven-year agreement to boost PAC-3 MSE production to about 2,000 interceptors per year; shares rose ~6% after earnings and updated guidance. These moves materially increase Lockheed’s production capacity and signal a strategic shift toward internal investment and defense build-up that is likely to influence defense sector allocations.

Analysis

Market structure: Lockheed (LMT) is a clear near-term winner — 2026 capex rising from $3.6B to $5B (+35%) and a THAAD build-rate jump from ~96 to 400 units over three years materially shifts airborne/ABM supply concentration to primes. Suppliers of precision electronics, specialty alloys and missile seekers (beneficiaries include RTX, NOC, GD supply chains) should see multi-year revenue visibility; consumer-facing defense contractors that rely on buybacks may be disadvantaged politically and competitively. Increased DoD long-duration contracts (seven-year PAC‑3 MSE ramp to ~2,000/yr) implies less spot-price competition and stronger pricing power for capacity holders.

Risk assessment: Tail risks include a reversal of procurement policy under political change, congressional appropriations shortfalls, or severe production bottlenecks (semiconductor/skill shortages) that blow 20–40% of expected delivery rates. Immediate (days) risk: post-earnings multiple expansion may retrace; short-term (weeks–months) risk: supplier bottleneck headlines; long-term (years) risk: capex failing to convert to free cash flow if margins erode or contracts are cost-plus. Hidden dependency: production ramp relies on tier‑2/3 subcontractors and export controls; catalysts to watch are DoD award notices, weekly backlog updates and congressional defense spending votes.

Trade implications: Tactical: establish a 2–3% long position in LMT over 1–12 months to capture production rerating, scaling in over 3 tranches as monthly backlog confirms ramp; complement with 1–2% longs in RTX and NOC as supply-chain plays. Relative-value: long LMT vs short small-cap defense names lacking secured multi-year contracts or high buyback exposure (XAR underperformers) to exploit funding/scale advantage. Options: buy 6–12 month call spreads on LMT to limit premium outlay or sell near-term covered calls to monetize a high-probability pop (target +15–25% upside exit).

Contrarian angles: The market may underprice margin pressure from input inflation and labor upskilling — higher capex can compress near-term EPS even if revenues rise, so the 6% pop could be overdone. Historical parallels: prior defense ramp-ups (post-9/11) produced strong backlog growth but multi-year execution slippage; unintended consequences include tighter raw-material markets (raising unit cost) and increased political oversight reducing buyback flexibility. Monitor weekly DoD contract awards, subcontractor lead times, and LMT’s free cash flow conversion across the next four quarters as triggers to add/reduce exposure.

Key Decisions for Investors

• Establish a 2–3% long position in LMT within 1–5 trading days, scale in three equal tranches over 3 months; target horizon 6–12 months and take profits if position rises +25% or if 2 consecutive months of backlog cadence misses guidance.
• Add 1% positions in RTX and NOC as supply-chain exposure (hold 6–18 months); trim if supplier lead-time reports show >20% slip or semiconductor shortages surface.
• Implement a 6–12 month LMT call spread to express upside with defined risk (buy ITM/near-ATM call, sell higher strike ~20–30% out) sized to cap portfolio risk at ~0.5–1% of NAV.
• Pair trade: go long LMT (2%) and short 1–1.5% in a small-cap defense ETF or name with >50% cash returns and no multi-year contracts (rotate if XAR underperforms by >5% relative to LMT over 30 days).
• Monitor triggers for liquidation: any failure to secure required FY appropriations or two consecutive monthly backlog misses → reduce LMT exposure by 50% within 7 trading days.